Vice President, U.S. Sales Greg Woods joins Viseon with over 20 years of experience in the spine industry.  Greg began his career in 2000 with Spinal Associates, exclusively representing Medtronic Sofamor Danek.  He served in  leadership roles of increasing seniority at Spinal Associates and finished his time there as a Distributor Principal.  Mr. Woods went on to take a leadership … Read More

Chief Operating Officer Pete has served as Viseon’s COO since August 2018.  Prior to joining Viseon, he was the CTO for Rebound Therapeutics the company from which Viseon was spun out.  Pete has held many positions during his twenty-five year career in medical devices primarily in start-up companies and corporate value building opportunities.  Pete has held management positions in R&D, … Read More

Board of Directors Mr. Henson has participated in the formation of more than twenty successful emerging medical technology and biotechnology firms and currently serves on the Board of Directors of four medical firms, and is Chairman of three of the companies.  Mr. Henson guided six of these firms through the IPO process to become public companies as President/CEO and/or Chairman, … Read More

Board of Directors Ron Bache is the President and CEO of Bache, Inc. and an Operating Partner with Invus Opportunities.  Bache was previously the President and CEO of AqueSys, Inc., a venture capital backed startup. AqueSys developed the XEN Gel Stent, the world’s first minimally invasive ab-interno  surgical procedure for the leading cause of irreversible blindness, glaucoma.  Bache joined AqueSys … Read More

President and Chief Executive Officer Mr. Valko has served as Viseon’s President and CEO since its inception in August 2017.  Prior to Viseon, Mr. Valko spent the first 25 years of his career in various Engineering and Business Development roles at Johnson & Johnson, American Hospital Supply and Baxter Healthcare.  During his Baxter tenure, he served a two-year ex-patriot assignment … Read More